|
Match
|
Document |
Document Title |
|
|
5977102 |
Pyrimido [5, 4-d] pyrimidines, pharmaceuticals containing these compounds, their use and processes for their preparation
Pyrimido[5,4-d]pyrimidines of the general formula ##STR1## which have an inhibitory effect on signal transduction mediated by tyrosine kinases, their use for the treatment of oncoses, and their...
|
|
|
5958929 |
6-aryl pyrazolo 3,4-d! pyrimidin-4-ones and compositions and methods of use thereof
6-Aryl pyrazolo 3,4-d!pyrimidin-4-one derivatives, pharmaceutical compositions containing them and methods for effecting c-GMP-phosphodiesterase inhibition and for treating heart failure and/or...
|
|
|
5925644 |
Substituted nitrogen heterocycles, processes for their preparation and their use as pesticides
Compounds of the formula I ##STR1## in which A is CH and D is N + R, A is nitrogen and D is N + R or A is N + R and D is nitrogen, R is --CR 4 R 5 --E--R 6 , Q n - is an inorganic or organic...
|
|
|
5889012 |
Substituted cycloalkylamino and cycloalkoxy heterocycles, processes for preparing them and their use as pesticides
Substituted cycloalkylamino and cycloalkoxy heterocycles, processes for preparing them and their use as pesticides The invention relates to (I) ##STR1## in which R 1 to R 5 , A, X, E, U, p and n...
|
|
|
5859009 |
Substituted spiroalkylamino and alkoxy heterocycles, processes for their preparation, and their use as pesticides and fungicides
Substituted spiroalkylamino and -alkoxy heterocycles, processes for their preparation, and their use as pesticides and fungicides The invention relates to compounds of the formula ##STR1## in which...
|
|
|
5821240 |
Pyrimido 5,4!-dipyrimidines, pharmaceuticals containing them, their use and processes for the preparation thereof
Pyrimido 5,4-d!pyrimidines of the general formula ##STR1## which have an inhibitory effect on signal transduction mediated by tyrosine kinases, their use for the treatment of disorders, in...
|
|
|
5780450 |
Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
Compositions and methods directed to the use of adenosine uptake inhibitors for the treatment of retinal and optic nerve head damage following acute or chronic glaucoma, edema, ischemia, hypoxia or...
|
|
|
5760028 |
Integrin receptor antagonists
This invention relates to novel heterocycles including 3- 1- 3-(imidazolin-2-ylamino)propyl!indazol-5-ylcarbonylamino!-2-
(benzylo xycarbonylamino)propionic acid, which are useful as antagonists of...
|
|
|
5756502 |
Quinazolinone derivatives as cholyecystokinin (CCK) ligands
Novel quinazolinone derivatives with good binding affinity for the CCK-A and CCK-B receptors, pharmaceutical compositions containing them, methods of using them and a novel process for their...
|
|
|
5747495 |
Method for treating hypertension using pyrazolopyrimidine derivatives
Antihypertensive agents containing as its active ingredient the 4-amino-6-hydroxypyrazolo 3,4-d!pyrimidine(AHPP) or its derivatives represented by the general formula (I) below. ##STR1## where R...
|
|
|
5707989 |
Pyrimido 5,4-D!pyrimidines, medicaments comprising these compounds, their use and processes for their preparation
The present invention relates to pyrimido 5,4-d!pyrimidines of the general formula ##STR1## in which R a to R c are as defined herein, their tautomers, their stereoisomers and their salts, in...
|
|
|
5679650 |
Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
A purine compound, which has a desired and an undesired effect when a dosage sufficient to induce the desired effect is administered to a mammal, is combined with a counteracting agent, wherein the...
|
|
|
5648314 |
Slow-dissolving multi-functional sanitizer and clarifier
A slow-dissolving sanitizing and clarifying puck for use in water such as swimming pool water preferably includes about 63% to about 80% trichloro-s-triazinetrione, about 4% to about 12% sodium...
|
|
|
5631258 |
Method of effecting immunosuppression by administering carbocyclic adenosine analogs
This invention relates to methods of effecting immunosuppression and inhibiting tumor necrosis factor α in a patient in need thereof comprising administering to said patient an effective...
|
|
|
5629298 |
Adenosine as a positive inotrop in the compromised heart
Disclosed are methods of increasing the contractile performance of a compromised myocardium in a mammal. The methods include administering a therapeutically affective amount of an adenosine A 2 ...
|
|
|
5614528 |
Compositions and methods for inhibiting the formation of chloramines and trihalomethanes in aqueous media
Compositions and methods are disclosed for sanitizing aqueous media, which combine a chlorine-source composition and a glycoluril-source composition. The compositions are added together or...
|
|
|
5593997 |
4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
Certain 4-aminopyrazolo[3,4-d]pyrimidine compounds, and their pharmaceutically-acceptable salts and prodrugs, are inhibitors of tyrosine kinase enzymes and are useful for immunoregulation and for...
|
|
|
5543433 |
Azine-substituted phenylacetic acid derivatives and fungicides containing these
Compounds of the formula I ##STR1## where X is hydrogen, halogen, alkyl, alkoxy, trifluoromethyl, cyano or nitro, Y is an amino, methylamino or dimethylamino group, Z is a group CHCH 3 ,...
|
|
|
5541187 |
6-heterocycyclyl pyrazolo[3,4-d]pyrimidin-4-ones and compositions and method of use thereof
Novel 6-heterocyclyl-pyrazolo[3,4-d]pyrimidin-4-ones, useful in treating cardiovascular disease, are prepared by reacting a 5-amino-1H-pyrazole-4-carboxamide with heterocyclyl-carboxaldehyde or by...
|
|
|
5508045 |
Method and agents for control and management of labor during pregnancy
A method for control, management and inhibition of a preterm labor by providing to a pregnant woman a donor of nitric oxide. Management and inhibition of preterm labor is achieved by administering...
|
|
|
5508277 |
Bicyclic pyrimidines
Novel bicyclic pyrimidine compounds for use as drugs and having formula (I). Said novel compounds and physiologically tolerable salts thereof may be used in therapeutics, particularly for...
|
|
|
5498613 |
Dipyridamole and analogs thereof in preventing adhesion formation
Compositions and methods for prevention of adhesion formation, whereby an effective amount of at least one compound selected from dipyridamole and analogs thereof is administered as active agent...
|
|
|
5478830 |
Fused-ring heterocycles for the treatment of atherosclerosis
This invention relates to pyrazolo pyrimidines for the treatment of atherosclerosis as inhibitors of acyl--CoA, cholesterol acyetransferase (ACAT), and their use as antihypercholesterolemic agents,...
|
|
|
RE35072 |
4-substituted pyrazolo[3,4-d]pyrimidine derivatives
4-Substituted pyrazolo[3,4-d]pyrimidine derivatives and a method of synthesis for the derivatives are described. The 4-substituted pyrazolopyrimidine derivatives are useful as cardiotonic agents...
|
|
|
5438060 |
Method of reducing elevated intraocular pressure
A method of reducing elevated intraocular pressure which comprises administering the compound of the formula (1): ##STR1## or a pharmaceutically acceptable salt thereof to patients suffering from...
|
|
|
5426107 |
Pyrazolopyrimidinone antianginal agents
Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof are selective cGMP PDE inhibitors which are useful in the treatment of such diseases and adverse conditions as...
|
|
|
5371098 |
Use of oxazole compounds to treat osteoporosis
An oxazole compound having the formula (I): ##STR1## in which A is a group of the formula --CH 2 OR 2 (wherein R 2 is a hydrogen atom, an optionally substituted hydrocarbon residue, an...
|
|
|
5350749 |
Pteridine derivatives
4-substituted-pyrido[3,2-d]pyridmidine, -pyrido[4,3-d]pyrimidine, -pyrido[3,4-d]pyrimidine, pyrido[2,3-d]pyrimidine, -pteridine, -pyrimido[4,5-d]pyrimidine, -pyrimido[4,5-c]pyridazine,...
|
|
|
5338740 |
Angiotensin II receptor antagonists
The present invention relates to novel heterocyclic derivatives of the formula Ar--W--Het wherein Ar, W and Het are as defined below, and related compounds, pharmaceutical compositions comprising...
|
|
|
5326764 |
Method for the treatment of hyperproliferative disorders
The present invention provides new methods for the treatment of hyperproliferative disorders of skin epidermal cells, particularly psoriasis, by administering 5-fluorouracil and dipyridamole, with...
|
|
|
5294612 |
6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
Novel 6-heterocyclyl-pyrazolo[3,4-d]pyrimidin-4-ones, useful in treating cardiovascular disease, are prepared by reacting a 5-amino-1H-pyrazole-4-carboxamide with heterocyclylcarboxaldehyde or by...
|
|
|
5272151 |
Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances
The present invention concerns aminoacyl and oligopeptidyl derivatives of allopurinol (1,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one) of general formula (I), and related salts with ##STR1##...
|
|
|
5242921 |
Compositions and methods for treating cutaneous hyperproliferative disorders
The present invention provides new methods for the treatment of hyperproliferative disorders of skin epidermal cells, particularly psoriasis, by administering methotrexate and dipyridamole, with...
|
|
|
5202328 |
Substituted fused pyrimidinones
Novel substituted fused pyrimidinones of formula (I), which are useful as angiotensin II antagonists, are disclosed. ##STR1##
|
|
|
5151426 |
2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
Methods and compositions for preventing or treating human immunodeficiency virus (HIV) infections characterized by 2-substituted-5-substituted-1,3-oxathiolanes.
|
|
|
5093116 |
Method of treating viral infection utilizing inteferon α and pipyridamole
A method of enhancing the antiviral activity of IFN-α and especially human IFN-α is disclosed which comprises administration of Dipyridamole or a pharmaceutically acceptable salt thereof to a...
|
|
|
5084482 |
Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
This invention concerns novel methods employing compositions containing as an active antioxidant or antiinflammatory agent the amino acid methionine, and/or one or more related compounds including...
|
|
|
5075310 |
Pyrimidone derivatives as bronchodilators
This invention relates to fused pyrimidine derivatives which have bronchodilator activity. A compound of this invention is 2-(2-propoxyphenyl)thieno[2,3-d]pyrimidin-4(3H)-one.
|
|
|
5075290 |
Use of adenosine, adenosine analogs or nucleoside uptake blockers, e.g. dipyridamole, as drug treatments for obstructive sleep apnea and snoring
Infusion of adenosine, adenoside analogs and nucleoside uptake blockers, e.g. dipyridamole, will decrease the number of apneas and associated oxyhemoglobin desaturation during sleep in patients...
|
|
|
5034393 |
Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives
Fungicidal compositions contain as active ingredient a 4-substituted-pyrido[3,2-d]pyrimidine, -pyrido[4,3-d]pyrimidine, -pyrido[3,4-d]pyrimidine, pyrido[2,3-d]pyrimidine, -pteridine,...
|
|
|
5010064 |
Inclusion complexes of dipyridamole with cyclodextrins
Inclusion complexes of dipyridamole with beta cyclodextrins in the molar ratio of dipyridamole to cyclodextrin ranging from 1:1 to 1:12 provides higher and more consistent blood concentrations than...
|
|
|
4981855 |
Medicament for psoriasis
Disclosed is a method of using medicaments for psoriasis containing 3-aminopyrazolo[3,4-d]pyrimidine compounds or their derivatives such as their salts and their glucuronides, which potently...
|
|
|
4980379 |
Use of adenosine antagonists in the treatment of bradyarrhythmias and hemodynamic depression associated with cardiopulmonary resucitation and/or cardiovascular collapse
A method to enhance the efficacy of cardioversion, defibrillation, cardiac pacing, and cardiopulmonary resuscitation and to treat post-resuscitation asystole, bradyarrhythmias, electromechanical...
|
|
|
4978668 |
Treatment to reduce ischemic tissue injury
Intravenous administration of allopurinol, oxypurinol or deferoxamine to a patient suffering a condition of tissue ischemia is effective to reduce damage to affected tissues. The invention has...
|
|
|
4963541 |
Pyrimido-pyrimidine lipoxygenase inhibiting compounds
Compounds of the formula: ##STR1## wherein A is selected from NR 1 R 2 and N(OR 6 )R 2 ; and B and C are chloro when A is N(OR 6 )R 2 or are independently selected from NHR 3 and NR 4 R 5 ...
|
|
|
4950648 |
Analgesic
New analgesic compositions containing a compound of the formula I ##STR1## wherein A--B is CH--CH or --N--CR 2 , Alk is an alkylene group having 2-4 C atoms, R 1 is H,...
|
|
|
4950466 |
Reduction of the severity of 3'-azido-3'-deoxythymidine-induced anemia using a combination of benzylacyclouridine and dipyridamole
The invention is directed to a method of inhibiting anemia caused by the administration of AZT to a patient which comprises administering to said patient an effective anemia-inhibiting amount of a...
|
|
|
4918075 |
Purinyl and pyrimidinyl cyclobutanes and their use as antiviral agents
Antiviral activity is exhibited by compounds having the formula ##STR1## its pharmaceutically acceptable salts thereof wherein R 2 and R 3 are independently hydrogen, --PO 3 H 2 or ##STR2## and...
|
|
|
4904666 |
Pyrazolo(3,4-d)pyrimidine compounds, compositions and method of use
The present invention provides pyrazolo[3,4-d]-pyrimidines of the general formula: ##STR1## wherein R 1 is a C 1 to C 6 -alkyl radical, a C 2 to C 6 -alkenyl radical, a C 3 to C 7 ...
|
|
|
4897394 |
Antiviral combinations
This invention relates to synergistic combinations of nucleoside analogues, which are converted to viral DNA polymerase inhibitors through the action of at least one virus-induced enzyme, and...
|